Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL - MCRPC): A Movember funded multicenter, randomized, controlled phase III study.

Saad, Fred; Kenfield, Stacey A; Chan, June M; Hart, Nicolas H; Courneya, Kerry S; Catto, James; Finn, Stephen P; Greenwood, Rosemary; Hughes, Daniel C; Mucci, Lorelei A; Plymate, Stephen R; Pollak, Michael N; Praet, Stephan FE; Russell, Aaron; Guinan, Emer M; Van Blarigan, Erin; Casey, Orla; Buzza, Mark; Ryan, Charles J; Newton, Robert Usher

Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL - MCRPC): A Movember funded multicenter, randomized, controlled phase III study.

conference contribution

posted on 2024-06-03, 21:20 authored by Fred Saad, Stacey A Kenfield, June M Chan, Nicolas H Hart, Kerry S Courneya, James Catto, Stephen P Finn, Rosemary Greenwood, Daniel C Hughes, Lorelei A Mucci, Stephen R Plymate, Michael N Pollak, Stephan FE Praet, Aaron RussellAaron Russell, Emer M Guinan, Erin Van Blarigan, Orla Casey, Mark Buzza, Charles J Ryan, Robert Usher Newton

Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL - MCRPC): A Movember funded multicenter, randomized, controlled phase III study.

History

Volume

34

Location

Chicago, IL

Start date

2016-06-03

End date

2016-06-07

ISSN

0732-183X

eISSN

1527-7755

Language

English

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404711501068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3 Extract of paper

Title of proceedings

JOURNAL OF CLINICAL ONCOLOGY

Event

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology 3202 Clinical sciences 3211 Oncology and carcinogenesis

Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL - MCRPC): A Movember funded multicenter, randomized, controlled phase III study.

History

Volume

Location

Start date

End date

ISSN

eISSN

Language

Author URL

Publication classification

Title of proceedings

Event

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports